会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • MICROSPHERES FOR THE SUSTAINED RELEASE OF OCTREOTIDE WITHOUT AN INITIAL TIME LAG
    • 在没有初始时间段的情况下持续释放奥曲肽的MICROSPHERES
    • WO2011087496A1
    • 2011-07-21
    • PCT/US2010/020895
    • 2010-01-13
    • OAKWOOD LABORATORIES LLCTHANOO, Bagavathikanun, ChithambaraJOHNS, Gonto
    • THANOO, Bagavathikanun, ChithambaraJOHNS, Gonto
    • A01N37/18
    • A61K9/1647A61K9/0024
    • Microspheres for releasing an octreotide compound without an initial time lag include a poly(D,L-lactide-co-glycolide) polymer (PLGA polymer) matrix having a ratio of lactide to glycolide ranging from 80:20 to 90: 10 mol%. The polymer has a molecular weight ranging from about 6000 to 16000. The octreotide compound is dispersed in the polymer matrix. The microspheres can be made by forming a dispersed phase by combining the above polymer, dichloromethane, the octreotide compound, methanol and acetic acid. A target loading of the octreotide compound in the dispersed phase ranges from 7 to 12% by weight. Polyvinyl alcohol is dissolved in water to form a continuous phase. The dispersed phase is mixed in the continuous phase to form a microsphere suspension. The dichloromethane, acetic acid, methanol and polyvinyl alcohol are removed from the microsphere suspension. Residual dichloromethane and methanol are removed from the microspheres by washing.
    • 用于释放没有初始时滞的奥曲肽化合物的微球包括丙交酯与乙交酯的比率为80:20至90:10mol%的聚(D,L-丙交酯 - 共 - 乙交酯)聚合物(PLGA聚合物)基质。 聚合物的分子量范围为约6000至16000.奥曲肽化合物分散在聚合物基质中。 可以通过将上述聚合物,二氯甲烷,奥曲肽化合物,甲醇和乙酸组合形成分散相来制备微球。 奥曲肽化合物在分散相中的靶装载量为7至12重量%。 将聚乙烯醇溶于水中形成连续相。 将分散相在连续相中混合以形成微球悬浮液。 从微球悬浮液中除去二氯甲烷,乙酸,甲醇和聚乙烯醇。 通过洗涤从微球中除去残留的二氯甲烷和甲醇。